{
    "links": "https://www.ycombinator.com/companies/general-proximity",
    "name": "General Proximity",
    "headline": "The next generation of induced-proximity medicines.",
    "batch": "W20",
    "description": null,
    "activity_status": "Active",
    "website": "https://www.generalproximity.bio/",
    "founded_date": null,
    "team_size": 15.0,
    "location": "San Francisco",
    "group_partner": "Jared Friedman",
    "group_partner_yc": "https://www.ycombinator.com/people/jared-friedman",
    "company_linkedin": null,
    "company_twitter": null,
    "tags": "industry:biotech; industry:drug-discovery; location:san-francisco-bay-area",
    "founders": [
        {
            "name": "Armand Cognetta, Founder",
            "description": "Armand completed his PhD in Chemical Biology at the Scripps Research Institute under the supervision of Dr. Benjamin F. Cravatt. There he co-authored 19 scientific publications in prestigious journals such as Cell, Nature, and Science, as well as multiple patents, including a portion of the foundational IP for Abide Therapeutics (acq. Lundbeck) and Vividion Therapeutics (acq. Bayer). Prior to founding GP he was an early employee at the Flagship Pioneering start-up Inzen Tx (now Sonata).",
            "linkedin": "https://www.linkedin.com/in/armandcognetta/"
        }
    ],
    "status": true,
    "generated_description": "### General Proximity: Revolutionizing Medicine Through Proximity\n\n**Company Overview:**\nGeneral Proximity, a forward-thinking biotech startup based in San Francisco, is taking on the challenge of drug discovery in a unique way. Founded during the Y Combinator W20 batch, this nimble team of around 15 is set on creating the next generation of induced-proximity medicines. Their vision is clear: redefine how we approach and develop therapeutics, making a meaningful impact on the future of medicine for everyone.\n\n**Mission:**\nThe core mission of General Proximity revolves around developing proximity medicines. According to them, proximity dictates biological processes \u2014 in their words, \"Control Proximity, Control Biology.\" Instead of following the conventional pathways of drug design, they aim to harness molecular interactions at close quarters to unlock new therapeutic potentials.\n\n**Technology and Approach:**\nThe company is pioneering what they call a \"generalized, mechanism-agnostic proximity discovery engine.\" This mechanism leverages the intricate network of effector proteins \u2014 these are the molecular machines that regulate biology at the most fundamental level. By mastering the interactions between target and effector proteins, General Proximity seeks to manipulate biological functions flexibly and effectively.\n\n**Collaborations:**\nGeneral Proximity has positioned itself alongside prestigious institutions like Johnson & Johnson, UCSF, and the Moffitt Cancer Center. These collaborations aim to accelerate the creation of next-gen proximity medicines, proving that the company is serious about tackling some of the toughest challenges in drug development.\n\n**Support and Growth:**\nThe company has received backing from prominent investors and strategic grants, including support from health-focused venture capital firms and entities like ARPA-H and the NCI. Their growing reputation is underscored by a record number of big pharma \u201cGolden Tickets.\u201d \n\n**Key Achievements:**\n- Over 36 FDA-approved medicines developed.\n- 146 Investigational New Drug Applications (INDs).\n- 245 patents awarded.\n- Nearly 1,000 scientific publications.\n\n**Join the Movement:**\nGeneral Proximity is on the lookout for talent. If you have a passion for innovation in medical science and want to be part of a team dedicated to overcoming the \"undruggables,\" they invite you to explore career opportunities.\n\n**In Summary:**\nGeneral Proximity is not just a biotech company; it\u2019s a trailblazer in the making. By focusing on the fundamental science of proximity, they're designing the next generation of medicines that could change the landscape of healthcare. With a clear mission, a strong foundation in partnerships, and a commitment to innovation, they\u2019re poised to make real waves in biomedicine. Check them out at [General Proximity](https://www.generalproximity.bio/). \n\nLet\u2019s keep an eye on their journey. Who knows what breakthroughs might be on the horizon?",
    "logo": "https://bookface-images.s3.us-west-2.amazonaws.com/logos/45169e6196fa0aa9e05dd167596ae0cad35ee7cf.png?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=ASIAQC4NIECAKBB576US%2F20250221%2Fus-west-2%2Fs3%2Faws4_request&X-Amz-Date=20250221T191356Z&X-Amz-Expires=3600&X-Amz-Security-Token=IQoJb3JpZ2luX2VjELP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJHMEUCIFRjVxB%2FHxIJHUHkMazoRi02jYmaJVJGr3K7C9j9jiflAiEA6iszI4%2Fpn8hDzk7aMP6LlnqynbPgCG20CpdZqslTFdsq7gMI3P%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FARAAGgwwMDYyMDE4MTEwNzIiDNVC6v4lNMvTlUOjTyrCA7R4NjcD6pWk9Gjux5NdrMhwU67pNo%2F0JVDzkHcTjBsajnWXpXoyD3m%2FssX0rwYmnUDJB9VTgD%2FW2M8cWxeD93WFxLjs25juzzGj1%2BC1Ky9E0oNPwn5jGw%2BjokWylkxcouU18mjUtP8juH4uF9Xfmm%2FMAgvOPsNSAaYBQ%2BdA5Vwom66MCzynAPEJs6Nqxd5FqtgiiWFRhT5L9g%2FvfLTKqpdIg0XPF6s95lLCtwWDHST72Bn9JVH2zZmqjTgO2sao7Rg4M%2BPIRazg8JhbPoWk6xsB2yfG1f%2Bs8AFVxihyUnQj6TUnhrhezs7WYsaTfaaAoTIzhEsLwJDqBQDSptmSlUj%2BQ3KWwrXpJIm0b1uOmaylnrEpn5obECdRc%2FzdEfNt6DNEE5cbUhQo8Gjfd6MWfyV7JHtX7DwsLMssQPKNZ6qWJq2gP1fVHFkz5K0F%2F73p54AKB5gCkyOeRPJHmAzYMdfZpMF%2B8hE4eZU6k7m1EqPLEW2F9HVvcqPFp8T%2BZgbbDLBVWICSdX%2FfJ%2BniwyC72aHLaqjCxHLvJ6WyAawaepaDD9csEvz4DYD9lpHx9hJXqrFDyrT1vAaaBwuoXgulZ6gNmjCmiuO9BjqlATnnhPFnQUT7QmhXwrAFbGCqdgkRFIVCdDrNmasZJtz86frmIpB%2BlwZjavL0FMq46mN9RKFTuRNdMnOtOh1adMI%2BkC%2F%2Bs3m8pwR56JxErG%2B8nIBe7efeu5WiUZbGCsp85oXBCGY%2FoP1uWrJo843L0LVdmjtyXaDurxXSgzfeZo2RDONME7LNkPzuGzA19XefIc9OvA1QFcZr3VIdZe%2BLywfFgDpgwA%3D%3D&X-Amz-SignedHeaders=host&X-Amz-Signature=e2fa84ca141c9549b62d3d3a31a63c377c4269d953b09e0c2144e2bb02e5a09c",
    "social_links": [
        "https://www.linkedin.com/company/generalproximity/",
        "https://x.com/proxbio"
    ],
    "logo_path": "data/logos\\General_Proximity_logo.png"
}